Abstract:Mitochondria are hubs of metabolic activity with a major role in ATP conversion by oxidative phosphorylation (OXPHOS). The mammalian mitochondrial genome encodes 11 mRNAs encoding 13 OXPHOS proteins along with 2 rRNAs and 22 tRNAs, that facilitate their translation on mitoribosomes. Maintaining the internal production of core OXPHOS subunits requires modulation of the mitochondrial capacity to match the cellular requirements and correct insertion of particularly hydrophobic proteins into the inner mitochondrial membrane. The mitochondrial translation system is essential for energy production and defects result in severe, phenotypically diverse diseases, including mitochondrial diseases that typically affect postmitotic tissues with high metabolic demands. Understanding the complex mechanisms that underlie the pathologies of diseases involving impaired mitochondrial translation is key to tailoring specific treatments and effectively targeting the affected organs. Disease mutations have provided a fundamental, yet limited, understanding of mitochondrial protein synthesis, since effective modification of the mitochondrial genome has proven challenging. However, advances in next generation sequencing, cryoelectron microscopy, and multi-omic technologies have revealed unexpected and unusual features of the mitochondrial protein synthesis machinery in the last decade. Genome editing tools have generated unique models that have accelerated our mechanistic understanding of mitochondrial translation and its physiological importance. Here we review the most recent mouse models of disease pathogenesis caused by defects in mitochondrial protein synthesis and discuss their value for preclinical research and therapeutic development.

Enzymatic tools for mitochondrial genome manipulation

Tools for editing the mammalian mitochondrial genome

Mitochondrial genome editing: strategies, challenges, and applications

Research Progress in Mitochondrial Gene Editing Technology.

Development of mitochondrial gene-editing strategies and their potential applications in mitochondrial hereditary diseases: a review

Mitochondrial diseases and mtDNA editing

Therapeutic and tampering approaches for mitochondrial associated diseases

Applications of Gene Editing in Mitochondrial Diseases

Interrogating Mitochondrial Biology and Disease Using CRISPR/Cas9 Gene Editing

New potentials of mitochondrial DNA editing

Targeted deletions in human mitochondrial DNA engineered by Type V CRISPR-Cas12a system

In vivo mitochondrial base editing via adeno-associated viral delivery to mouse post-mitotic tissue

Direct Evidence of CRISPR-Cas9-mediated Mitochondrial Genome Editing

Strand-selective base editing of human mitochondrial DNA using mitoBEs

Selective Elimination of Mitochondrial Mutations in the Germline by Genome Editing

CRISPR/Cas9-mediated base editors and their prospects for mitochondrial genome engineering

Streamlined process for effective and strand-selective mitochondrial base editing using mitoBEs

Illuminating mitochondrial translation through mouse models

Engineered mitochondrial A-to-G editors with enhanced efficiency and targeting scope

Therapeutic potential of engineering the mitochondrial genome.

Adapting CRISPR/Cas9 System for Targeting Mitochondrial Genome